Injectables AbbVie files sNDA to FDA for chronic graft versus host disease therapy By Esthetic Advisor - September 21, 2022 0 102 Facebook Twitter Pinterest WhatsApp AbbVie files sNDA to FDA for chronic graft versus host disease therapy Pharmaceutical Business review is using cookies Close Source link